Search

everythinglearnresearchcommunity

for

Search:↓

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Androstenedione is better than testosterone for diagnosing PCOS in Indian women.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

Neurosteroids like neuro-estrogen and neuro-androgen are crucial for brain function and can improve cognition and protect against aging-related decline.

Hair loss in balding individuals is linked to changes in specific hair growth-related genes.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

South Korean women with hair loss have lower hair density and thickness compared to healthy women.

Higher DHT levels are linked to more acne in adolescents, especially boys.

Alopecia patients have higher heart disease risk; statins and finasteride may help.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Higher testosterone and DHT levels are not linked to urinary symptoms in men.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Baicalin may help reduce excessive male hormone levels in PCOS.

Finasteride reduces DHT levels and affects gene expression in fish, similar to its effects in humans.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Going to bed late may increase hormones and decrease muscle in women with PCOS.

Higher LDL cholesterol may increase the risk of hair loss, while HDL cholesterol does not.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

High doses of testosterone disrupt hormone levels and receptor expression in the uterus, affecting fertility.

Cardiac risk markers help assess heart risk in males with type 2 diabetes and low DHT.

People with hair loss have different hormone levels, and these hormones can affect hair growth.

Women with androgenetic alopecia often have other symptoms of high androgen levels, requiring further hormone testing.

Many women with PCOS have abnormal cholesterol levels, needing careful management.

Surgery removed an ovarian tumor, improving her symptoms and normalizing testosterone levels.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

CT scans can find serious prostate cancer even when PSA levels are low.